CVS Health Corp (CVS)
67.43
+0.83 (1.25%)
NYSE · Last Trade: Jul 3rd, 5:56 PM EDT
Detailed Quote
Previous Close | 66.60 |
---|---|
Open | 66.92 |
Bid | 67.25 |
Ask | 67.50 |
Day's Range | 66.63 - 67.78 |
52 Week Range | 43.56 - 72.51 |
Volume | 3,770,990 |
Market Cap | 88.98B |
PE Ratio (TTM) | 16.05 |
EPS (TTM) | 4.2 |
Dividend & Yield | 2.660 (3.94%) |
1 Month Average Volume | 6,890,854 |
Chart
About CVS Health Corp (CVS)
CVS Health Corp is a diversified healthcare company that operates a vast network of retail pharmacies, providing prescription medications, over-the-counter products, and health and wellness services. In addition to its retail operations, CVS Health also offers pharmacy benefit management services, helping manage prescription drug costs for businesses and health plans. The company is involved in providing health insurance and health services through its various divisions, including a growing presence in digital health solutions and immunization services. By integrating pharmacy services with healthcare delivery, CVS Health aims to enhance patient care and improve health outcomes across the communities it serves. Read More
News & Press Releases
Via Benzinga · July 3, 2025
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Oscar Health (NYSE:OSCR) and the best and worst performers in the health insurance providers industry.
Via StockStory · July 2, 2025
Synergy CHC Corp. (NASDAQ: SNYR) has surged over 74% in the last 30 days, fueled by the execution of a sweeping retail expansion strategy for its flagship FOCUSfactor® brand, now available in both supplement and functional beverage form. The brand’s rollout to over 50,000 locations —via Core-Mark, Walmart Canada, Metro Ontario, and Downey Wholesale—marks a major milestone, unlocking national reach across mass retail, grocery, convenience, and independent channels.
Via AB Newswire · July 2, 2025

Via The Motley Fool · July 1, 2025
Synergy CHC Corp. (NASDAQ: SNYR), a rising consumer staple health company, has announced a wave of major expansion throughout North American for its FOCUSfactor® supplements and functional beverage brands, across mass, grocery, convenience, and wholesale channels. Functional Beverage Momentum
Via AB Newswire · June 30, 2025
Via Benzinga · June 30, 2025
The case stems from a whistleblower lawsuit filed by a former Aetna actuary who alleged CVS Caremark manipulated drug pricing to inflate Medicare claims while underpaying pharmacies.
Via Stocktwits · June 26, 2025
Shares of CVS Health are trading higher Thursday afternoon. The stock is climbing after a GOP healthcare bill hit a roadblock in the Senate.
Via Benzinga · June 26, 2025
The provisions at risk include the plan to hold down Medicaid costs by cracking down on a state provider tax.
Via Stocktwits · June 26, 2025
Each stock in this article is trading near its 52-week high.
These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.
Via StockStory · June 26, 2025
Several major U.S. health insurers announce they will voluntarily speed up and simplify the prior authorization process.
Via Benzinga · June 23, 2025
Donald Trump Jr. has joined Mark Cuban in publicly voicing disapproval of Sen. Elizabeth Warren's approach to healthcare pricing.
Via Benzinga · June 21, 2025
Via Benzinga · June 20, 2025
A debate over the healthcare system erupted on X, pitting Mark Cuban against Elizabeth Warren over the root causes of soaring drug prices.
Via Benzinga · June 20, 2025
The research firm expects lower enrollment growth as UnitedHealth exits unprofitable plans and prioritizes margin discipline.
Via Stocktwits · June 19, 2025
The draft Senate bill introduces stricter work requirements and funding curbs for Medicaid, while shelving proposed Medicare cuts that could have impacted major insurers.
Via Stocktwits · June 16, 2025
Several major large-cap stocks, each with a market capitalization of over $30 billion, have recently announced notable increases to their quarterly dividends. These updates, aligned with recent shareholder meetings and strategic decisions, reflect efforts to enhance shareholder value and demonstrate financial strength.
Via MarketBeat · June 16, 2025
Via The Motley Fool · June 14, 2025
Synergy CHC Corp. (NASDAQ: SNYR), a fast-rising force in the consumer health and wellness space, has appointed Damian Marano as Vice President of Beverage in a strategic move aimed at catapulting the company’s FOCUSfactor Energy Drink into global markets. Marano, a seasoned executive with a decorated history at The Coca-Cola Company (NYSE: KO), brings a wealth of expertise that could unlock powerful international distribution opportunities for the brand.
Via AB Newswire · June 10, 2025

Humana is joining lawmakers in support of limiting Medicare Advantage payments tied to home visit diagnoses.
Via Benzinga · June 5, 2025

Synergy CHC Corp. (NASDAQ: SNYR), a provider of consumer health and lifestyle products, most notably “Focusfactor” , today announced a transformative $20 million financing agreement with ACP Agency, LLC , aimed at reducing legacy debt, boosting liquidity, and accelerating the company’s global growth strategy.
Via AB Newswire · June 4, 2025

Nearly 80% of S&P 500 firms beat Q1 earnings forecasts. Profit growth hit 13.3%, led by tech and health care, says FactSet.
Via Benzinga · June 3, 2025

Amazon Pharmacy introduces caregiver support and expands PillPack access for Medicare users, simplifying medication routines with secure tools and pre-sorted packets.
Via Benzinga · June 3, 2025